Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies

2007193 citationsJournal Articlebronze Open Access

Authors

Denis Caillot · Maison des Sciences de l’Homme de Dijon

Anne Thiébaut · Hospices Civils de Lyon

Raoul Herbrecht · Université de Strasbourg

Stéphane de Botton · Université de Lille

Arnaud Pigneux · Bordeaux Population Health

Frédéric Bernard · Centre Hospitalier Universitaire de Montpellier

Jérôme Larché

Abstract

The combination of liposomal AmB and caspofungin was promising as therapy for IA compared with monotherapy. A trial that includes more patients will be required next to confirm the results of this pilot study.

Topics & Keywords

Antifungal resistance and susceptibility Fungal Infections and Studies Infectious Diseases and Mycology

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Cancer

Volume 110, Issue 12, pp. 2740-2746

DOI: 10.1002/cncr.23109

Field-Weighted Citation Impact: 10.08